CMS and FDA Launch ACCESS and TEMPO Programs to Promote Outcome-Based Chronic Care
CMS and FDA introduce ACCESS and TEMPO programs to foster value-based reimbursement and regulatory flexibility for digital health technologies targeting chronic conditions starting 2026.